352 related articles for article (PubMed ID: 23636772)
21. Emerging vascular cell-specific roles for mineralocorticoid receptor: implications for understanding sex differences in cardiovascular disease.
Wolter NL; Jaffe IZ
Am J Physiol Cell Physiol; 2023 Jan; 324(1):C193-C204. PubMed ID: 36440858
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells.
Rautureau Y; Paradis P; Schiffrin EL
Steroids; 2011 Aug; 76(9):834-9. PubMed ID: 21371487
[TBL] [Abstract][Full Text] [Related]
23. Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension After Preeclampsia.
Biwer LA; Lu Q; Ibarrola J; Stepanian A; Man JJ; Carvajal BV; Camarda ND; Zsengeller Z; Skurnik G; Seely EW; Karumanchi SA; Jaffe IZ
Circ Res; 2023 Mar; 132(6):674-689. PubMed ID: 36815487
[TBL] [Abstract][Full Text] [Related]
24. Rapid non-genomic effects of aldosterone on rodent vascular function.
Uhrenholt TR; Schjerning J; Rasmussen LE; Hansen PB; Nørregaard R; Jensen BL; Skøtt O
Acta Physiol Scand; 2004 Aug; 181(4):415-9. PubMed ID: 15283753
[TBL] [Abstract][Full Text] [Related]
25. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.
Davel AP; Jaffe IZ; Tostes RC; Jaisser F; Belin de Chantemèle EJ
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H989-H999. PubMed ID: 29957022
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone, the Mineralocorticoid Receptor and Mechanisms of Cardiovascular Disease.
Young MJ; Adler GK
Vitam Horm; 2019; 109():361-385. PubMed ID: 30678863
[TBL] [Abstract][Full Text] [Related]
27. [Respective roles of cortisol, aldosterone and angiotensin II during pathophysiology of atherosclerosis].
Ayari H
Ann Biol Clin (Paris); 2013; 71(4):381-8. PubMed ID: 23906564
[TBL] [Abstract][Full Text] [Related]
28. The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.
Funder JW
Am J Cardiovasc Drugs; 2007; 7(3):151-7. PubMed ID: 17610342
[TBL] [Abstract][Full Text] [Related]
29. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
Bender SB; McGraw AP; Jaffe IZ; Sowers JR
Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535
[TBL] [Abstract][Full Text] [Related]
30. Placental growth factor mediates aldosterone-dependent vascular injury in mice.
Jaffe IZ; Newfell BG; Aronovitz M; Mohammad NN; McGraw AP; Perreault RE; Carmeliet P; Ehsan A; Mendelsohn ME
J Clin Invest; 2010 Nov; 120(11):3891-900. PubMed ID: 20921624
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone in vascular and metabolic dysfunction.
Luther JM
Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
[TBL] [Abstract][Full Text] [Related]
32. Does Aldosterone Play a Significant Role for Regulation of Vascular Tone?
Lyngsø KS; Assersen K; Dalgaard EG; Skott O; Jensen BL; Hansen PB
J Cardiovasc Pharmacol; 2016 Jul; 68(1):1-10. PubMed ID: 26657712
[TBL] [Abstract][Full Text] [Related]
33. Cooperative Role of Mineralocorticoid Receptor and Caveolin-1 in Regulating the Vascular Response to Low Nitric Oxide-High Angiotensin II-Induced Cardiovascular Injury.
Pojoga LH; Yao TM; Opsasnick LA; Siddiqui WT; Reslan OM; Adler GK; Williams GH; Khalil RA
J Pharmacol Exp Ther; 2015 Oct; 355(1):32-47. PubMed ID: 26183312
[TBL] [Abstract][Full Text] [Related]
34. The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction.
Caprio M; Mammi C; Jaffe IZ; Zennaro MC; Aversa A; Mendelsohn ME; Fabbri A; Rosano GM
Curr Pharm Des; 2008; 14(35):3749-57. PubMed ID: 19128227
[TBL] [Abstract][Full Text] [Related]
35. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure.
Nguyen Dinh Cat A; Griol-Charhbili V; Loufrani L; Labat C; Benjamin L; Farman N; Lacolley P; Henrion D; Jaisser F
FASEB J; 2010 Jul; 24(7):2454-63. PubMed ID: 20299606
[TBL] [Abstract][Full Text] [Related]
36. Mineralocorticoid Receptor and Aldosterone-Related Biomarkers of End-Organ Damage in Cardiometabolic Disease.
Gorini S; Marzolla V; Mammi C; Armani A; Caprio M
Biomolecules; 2018 Sep; 8(3):. PubMed ID: 30231508
[TBL] [Abstract][Full Text] [Related]
37. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.
Usher MG; Duan SZ; Ivaschenko CY; Frieler RA; Berger S; Schütz G; Lumeng CN; Mortensen RM
J Clin Invest; 2010 Sep; 120(9):3350-64. PubMed ID: 20697155
[TBL] [Abstract][Full Text] [Related]
38. The Mineralocorticoid Receptor in the Vasculature: Friend or Foe?
Ibarrola J; Jaffe IZ
Annu Rev Physiol; 2024 Feb; 86():49-70. PubMed ID: 37788489
[TBL] [Abstract][Full Text] [Related]
39. Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.
McGraw AP; Bagley J; Chen WS; Galayda C; Nickerson H; Armani A; Caprio M; Carmeliet P; Jaffe IZ
J Am Heart Assoc; 2013 Feb; 2(1):e000018. PubMed ID: 23525413
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
Pojoga LH; Adamová Z; Kumar A; Stennett AK; Romero JR; Adler GK; Williams GH; Khalil RA
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H1776-88. PubMed ID: 20363891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
